Genmab — April 2024

[E_L]

Jefferies analysts previously predicted Epkinly could reach about $2.75 billion in peak sales.

[E_L]

Take your pick

[E_L]

the strength of the competition will greatly affect epco sales, it will be a battle

[lahn1]

wise guy

[E_L]

jyskebank monthly
https://www.jyskebank.dk/wps/wcm/connect/jfo/eb0962c6-b617-408e-8245-d9efbb1679e3/Danske+Aktier+-+April+2024.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE.Z18_P20418S0N05640Q0MBPDFT1PE7-eb0962c6-b617-408e-8245-d9efbb1679e3-oYK6XHG

[royal]

"Vi anbefaler, at investorerne stille og
roligt begynder at stige ombord på toget, inden det kører." Zzzzzzzzzzzzzzzzzzz

[royal]

KYSO. att.: Helge: "Den tålmodige investor II" bør handle om Genmab investorere.

[w]

jyske undrer sig også over fald ovenpå positive nyheder

[lahn1]

Det skrev Jyske også for 3 mdr siden

[Raun]

Hvor er det da ved at være pinligt for Jyske Bank.... - Hold nu op, hvor har de gentaget sig selv mange gange igennem de seneste måneder.... - De må have et ordentlig læs aktier de meget gerne vil af med

[GeorgeBest]

Thanks E L. Do you know how the forecasters see the market share split between epco versus glofi/monesu? 50/50?

[E_L]

no, i don't. would be fun indeed to look at these same analysts forecasts for that

[E_L]

Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Dr. Judith Klimovsky to serve as an independent director on the Company's Board of Directors https://investors.bio-techne.com/press-releases/detail/418/bio-techne-appoints-dr-judith-klimovsky-to-board-of -Bio-Techne is a leading supplier of high quality and innovative tools for Life Science Research, Therapeutic Manufacturing and Clinical Diagnostics.

[E_L]

the new Endometrial Cancer trial with GEN1046 will not continue; due to [Enrollment challenged by availability of other treatment options] https://classic.clinicaltrials.gov/ct2/history/NCT06046274?A=10&B=11&C=merged#StudyPageTop

[E_L]

it seems no patients were recruited yet, so the costs should be limited

[E_L]

New trial - Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy (HexaBody-OX40) https://clinicaltrials.gov/study/NCT06391775

[E_L]

TECVAYLI available in Spain from may1 https://www.vademecum.es/noticia-240430-Disponible+en+Espa+ntilde+a+++9660+TECVAYLI+sup++reg+++sup+++teclistamab+++el+primer+anticuerpo+biespec+iacute+fico+anti++BCMA+sup++1++sup++autorizado+para+el+tratamiento+de+pacientes+triple+expuestos+con+mieloma+m+uacute+ltiple_90351

[lahn1]

Hvorlænge skal man havde været aktionær i Gmab for at kunne kalde sig for En Tålmodig Invester ?

[Vitus]

Godt spørgsmål, men jeg er overbevist om, at mange har mistet tålmodigheden !

[JKY_VH]

Alt godt kommer til den der har tålmodigheden til at vente;-)